SCHEMBL24258324

SCHEMBL24258324

CCCNCc1cc(C(F)(F)F)ccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 7/20 0.43
NOS3 P29474 1/20 0.42
NOS2 P35228 1/20 0.42
GLS O94925 3/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADRB2 P07550 1/20 0.40
CYP2D6 P10635 2/20 0.39
PSEN1 P49768 2/20 0.39
PSEN2 P49810 2/20 0.39
APH1B Q8WW43 2/20 0.39
NCSTN Q92542 2/20 0.39
APH1A Q96BI3 2/20 0.39
PSENEN Q9NZ42 2/20 0.39
SCN8A Q9UQD0 1/20 0.39
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
MBOAT4 Q96T53 1/20 0.38
PLK1 P53350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288352 0.87 NOS3 (0.44) SIRT2NOS3NOS2GLSALDH1A1
SCHEMBL13185361 0.80 NOS3 (0.47) NOS3NOS2GLSALDH1A1GAA
SCHEMBL10254409 0.79 ADRB2 (0.56) NOS3NOS2GLSALDH1A1GAA
SCHEMBL21503646 0.78 CYP2D6 (0.52) NOS3NOS2ALDH1A1GAAL3MBTL1
SCHEMBL2616106 0.78 NOS3 (0.52) NOS3NOS2GLSALDH1A1GAA
SCHEMBL26913694 0.77 NOS3 (0.47) NOS3NOS2GLSALDH1A1GAA
SCHEMBL13167405 0.76 TRPV3 (0.45) NOS3NOS2GLSALDH1A1GAA
SCHEMBL30481847 0.76 KDM1A (0.46) GLSGAASCN8APOLBMBOAT4
SCHEMBL24258303 0.76 KDM1A (0.46) GLSGAASCN8APOLBMBOAT4
SCHEMBL28283856 0.76 NOS3 (0.46) NOS3NOS2GLSALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed